Literature DB >> 16107719

Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface.

Jessica P Dawson1, Mitchell B Berger, Chun-Chi Lin, Joseph Schlessinger, Mark A Lemmon, Kathryn M Ferguson.   

Abstract

Structural studies have shown that ligand-induced epidermal growth factor receptor (EGFR) dimerization involves major domain rearrangements that expose a critical dimerization arm. However, simply exposing this arm is not sufficient for receptor dimerization, suggesting that additional ligand-induced dimer contacts are required. To map these contributions to the dimer interface, we individually mutated each contact suggested by crystallographic studies and analyzed the effects on receptor dimerization, activation, and ligand binding. We find that domain II contributes >90% of the driving energy for dimerization of the extracellular region, with domain IV adding little. Within domain II, the dimerization arm forms much of the dimer interface, as expected. However, a loop from the sixth disulfide-bonded module (immediately C-terminal to the dimerization arm) also makes a critical contribution. Specific ligand-induced conformational changes in domain II are required for this loop to contribute to receptor dimerization, and we identify a set of ligand-induced intramolecular interactions that appear to be important in driving these changes, effectively "buttressing" the dimer interface. Our data also suggest that similar conformational changes may determine the specificity of ErbB receptor homo- versus heterodimerization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107719      PMCID: PMC1190273          DOI: 10.1128/MCB.25.17.7734-7742.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

Review 1.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

2.  Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.

Authors:  M Odaka; D Kohda; I Lax; J Schlessinger; F Inagaki
Journal:  J Biochem       Date:  1997-07       Impact factor: 3.387

3.  Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.

Authors:  R R Beerli; N E Hynes
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

Review 4.  Epidermal growth factor-related peptides and their receptors in human malignancies.

Authors:  D S Salomon; R Brandt; F Ciardiello; N Normanno
Journal:  Crit Rev Oncol Hematol       Date:  1995-07       Impact factor: 6.312

5.  Extracellular domains drive homo- but not hetero-dimerization of erbB receptors.

Authors:  K M Ferguson; P J Darling; M J Mohan; T L Macatee; M A Lemmon
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

6.  Two EGF molecules contribute additively to stabilization of the EGFR dimer.

Authors:  M A Lemmon; Z Bu; J E Ladbury; M Zhou; D Pinchasi; I Lax; D M Engelman; J Schlessinger
Journal:  EMBO J       Date:  1997-01-15       Impact factor: 11.598

7.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

8.  ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface.

Authors:  Mitchell B Berger; Jeannine M Mendrola; Mark A Lemmon
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

9.  Expression of epidermal growth factor receptors in human brain tumors.

Authors:  T A Libermann; N Razon; A D Bartal; Y Yarden; J Schlessinger; H Soreq
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

10.  Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas.

Authors:  V Gorgoulis; D Aninos; P Mikou; P Kanavaros; A Karameris; J Joardanoglou; A Rasidakis; M Veslemes; B Ozanne; D A Spandidos
Journal:  Anticancer Res       Date:  1992 Jul-Aug       Impact factor: 2.480

View more
  123 in total

1.  Targeting the dimerization of epidermal growth factor receptors with small-molecule inhibitors.

Authors:  Robert Y C Yang; Katherine S Yang; Linda J Pike; Garland R Marshall
Journal:  Chem Biol Drug Des       Date:  2010-05-04       Impact factor: 2.817

2.  Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.

Authors:  Rebecca A Scheck; Melissa A Lowder; Jacob S Appelbaum; Alanna Schepartz
Journal:  ACS Chem Biol       Date:  2012-06-05       Impact factor: 5.100

3.  Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.

Authors:  Zhiyong Zhang; Willy Wriggers
Journal:  Biochemistry       Date:  2011-02-18       Impact factor: 3.162

4.  Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic.

Authors:  Sashikanth Banappagari; Miriam Corti; Seth Pincus; Seetharama Satyanarayanajois
Journal:  J Biomol Struct Dyn       Date:  2012-06-26

5.  The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.

Authors:  Sangeeta Adak; Diana DeAndrade; Linda J Pike
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

Review 6.  Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.

Authors:  Tzipora Goldkorn; Simone Filosto; Samuel Chung
Journal:  Antioxid Redox Signal       Date:  2014-07-01       Impact factor: 8.401

7.  On the nature of low- and high-affinity EGF receptors on living cells.

Authors:  Ferruh Ozcan; Peter Klein; Mark A Lemmon; Irit Lax; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-29       Impact factor: 11.205

8.  Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.

Authors:  Kaleeckal G Harikumar; Maoqing Dong; Zhijie Cheng; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

Review 9.  Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.

Authors:  Kathryn M Ferguson; Chun Hu; Mark A Lemmon
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

Review 10.  Interaction of antibodies with ErbB receptor extracellular regions.

Authors:  Karl R Schmitz; Kathryn M Ferguson
Journal:  Exp Cell Res       Date:  2008-10-22       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.